| answer text |
<p>Over the last 5 financial years (2018/19 to 2022/23) the Foreign, Commonwealth
and Development Office (FCDO) have invested the following amounts in research and
development for vaccines to combat diseases of poverty for use in low and lower middle-income
countries:</p><table><tbody><tr><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>£8,528,752</p></td><td><p>£29,589,803</p></td><td><p>£213,773,395</p></td><td><p>£2,391,511</p></td><td><p>£13,012,567</p></td></tr></tbody></table><p>To
date, FCDO has entered into agreements to invest the following amounts on vaccine
Research and Development over the next 5 financial years (2023/24 to 2027/28)*:</p><table><tbody><tr><td><p>2023/24</p></td><td><p>2024/25</p></td><td><p>2025/26</p></td><td><p>2026/27</p></td><td><p>2027/28</p></td></tr><tr><td><p>£17,008,587</p></td><td><p>£18,626,489</p></td><td><p>£17,253,808</p></td><td><p>£17,000,000</p></td><td><p>£0</p></td></tr></tbody></table><p>*
The overall investment in vaccine development could increase as a result of a planned
funding competition for the research and development of health products to combat
diseases of poverty.</p>
|
|
